1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. L Brands
  6. News
  7. Summary
    LB   US5017971046

L BRANDS

(LB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Bath & Body Works : 4Q 2021 Earnings Commentary

01/06/2022 | 07:48am EDT

Final

1

BBWI FOURTH QUARTER EARNINGS UPDATE

JANUARY 6, 2022

  • Happy new year! Bath & Body Works is providing this additional commentary related to its press release today updating fourth quarter earnings guidance.
  • Any forward-looking statements contained in this commentary are subject to the safe harbor statement found in our SEC filings.
  • Holiday (November and December) sales were above expectations with strong customer response across all categories. Fragrant body care and home fragrance sales increased substantially compared to last year. As expected, soap and sanitizer sales were down compared to last year, but up meaningfully compared to 2019.
  • Overall holiday promotional activity was consistent with our projections. Customers responded well to our key promotional events, and business in the week before Christmas was strong.
  • We are currently in our semi-annual sale, which started the day after Christmas. It is currently performing below our expectations, and we will continue to make promotional adjustments to end the year with clean inventories.
  • We expect total fourth quarter sales at the high end of our guidance for a mid- to high-single digit percent increase compared to 2020.
  • We expect our fourth quarter gross margin rate to be down significantly compared to last year, consistent with the guidance we provided on our third quarter earnings call. As noted on that call, this decline is the result of inflationary cost increases which have only been partially offset by retail price increases.
  • We expect that fourth quarter earnings per share will be at the high end of our previous guidance of $2.10 to $2.25, compared to earnings per share from continuing operations of $1.96 in 2020.
  • We will report fourth quarter earnings on Feb. 23, 2022.

Final

2

  • Thank you for your continuing interest in Bath & Body Works.

Disclaimer

Bath & Body Works Inc. published this content on 06 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 January 2022 12:47:05 UTC.


ę Publicnow 2022
All news about L BRANDS
07:40aJPMorgan Adjusts Price Target on Bath & Body Works to $67 From $81, Reiterates Overweig..
MT
05/13BATH & BODY WORKS, INC. : Change in Directors or Principal Officers, Submission of Matters..
AQ
05/13Bath & Body Works, Inc. Announces Board Changes
CI
05/13Bath & Body Works, Inc. Announces Chief Executive Officer Changes
CI
05/13Bath & Body Works Keeps Dividend at $0.20 Per Share, Payable June 17 to Shareholders of..
MT
05/13Bath & Body Works Declares Cash Dividend
AQ
05/13Bath & Body Works Declares Cash Dividend, Payable on June 17, 2022
CI
05/05Bath & Body Works Invites You to Listen to the First Quarter 2022 Earnings Call Webcast
AQ
05/05BATH & BODY WORKS, INC. : Change in Directors or Principal Officers, Financial Statements ..
AQ
04/05Wells Fargo Adjusts Price Target on Bath & Body Works to $70 From $85, Reiterates Overw..
MT
More news
Analyst Recommendations on L BRANDS
More recommendations
Financials (USD)
Sales 2023 8 127 M - -
Net income 2023 1 083 M - -
Net Debt 2023 3 696 M - -
P/E ratio 2023 11,2x
Yield 2023 1,56%
Capitalization 12 165 M 12 165 M -
EV / Sales 2023 1,95x
EV / Sales 2024 1,83x
Nbr of Employees 32 850
Free-Float 88,7%
Chart L BRANDS
Duration : Period :
L Brands Technical Analysis Chart | LB | US5017971046 | MarketScreener
Technical analysis trends L BRANDS
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 51,01 $
Average target price 80,53 $
Spread / Average Target 57,9%
EPS Revisions
Managers and Directors
Sarah Elizabeth Nash Executive Chairman & Chief Executive Officer
Julie Rosen President
Wendy C. Arlin Chief Financial Officer & Executive Vice President
Chris Cramer Chief Operating Officer
Michael G. Morris Independent Director
Sector and Competitors
1st jan.Capi. (M$)
L BRANDS-26.91%12 165
ULTA BEAUTY, INC.-3.99%20 676
E.L.F. BEAUTY, INC.-28.58%1 236
SA SA INTERNATIONAL HOLDINGS LIMITED-18.56%538
LYKO GROUP AB (PUBL)-45.87%309
PHARMASGP HOLDING SE-1.21%305